Clinical trial
Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant…
NCT00084266 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00084266 |
|---|---|
| Title | Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA) |
| Official title | Linezolid In The Treatment Of Subjects With Nosocomial Pneumonia Proven To Be Due To Methicillin-Resistant Staphylococcus Aureus |
| Acronym | ZEPHYR |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Methicillin Resistant Staphylococcus Aureus (MRSA) |
| Intervention type | Drug |
| Interventions | linezolid (Zyvox), vancomycin |
| Enrollment | 1,225 |
| Start date | Oct 1, 2004 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Jun 11, 2004 |
| Last update posted | Feb 1, 2012 |
| Countries | Argentina, Belgium, Brazil, Chile, Colombia, France, Germany, Greece, Hong Kong, Malaysia, Mexico, Poland and 10 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: